The Best Dividend ETF to Buy and Hold, According to 15 Years of History

The $108 billion Schwab U.S. Dividend Equity ETF (SCHD) has returned 532% since its launch nearly 15 years ago, while its 30-day SEC yield is 3.4% and its expense ratio is 0.06%. The article highlights its long-term record, income profile and value-oriented diversification, including 41.1% combined exposure to healthcare and consumer staples and 9.2% to technology.

Analysis

The useful implication is portfolio construction, not a fresh signal on the market: SCHD offers a different sector and factor mix from growth-heavy benchmarks, but its recent relative performance will remain sensitive to whether leadership broadens beyond mega-cap growth. Its healthcare/staples tilt can cushion a growth-led drawdown, yet may lag if falling rates and durable growth expectations keep long-duration equities in favor. The dividend itself is not incremental return; distributions can be offset by price moves, and a high payout focus can concentrate exposure in mature sectors.

Near term, a promotional case for the fund is not a catalyst. Over 1–3 months, relative performance is more likely to turn on rate expectations, earnings breadth, and whether defensive sectors participate. Over 6–18 months, the key question is whether dividend growth and cash-flow resilience compensate for lower exposure to the market’s growth leaders. The article provides no current valuation, holdings concentration, or distribution-growth data to establish that trade-off is attractive today. A sustained rise in long-term yields or renewed narrow growth leadership would weaken the relative case; broadening earnings and defensive-sector strength would support it.

Key Decisions for Investors

• No event-driven trade: the article is a long-horizon allocation argument, not new evidence of improving fundamentals or a near-term catalyst.
• For portfolios materially concentrated in growth/technology, consider staged SCHD exposure as a diversification sleeve rather than replacing core equity exposure. Size against sector and factor overlap, not headline yield.
• Watch the SCHD-versus-broad-market relative trend alongside long-term Treasury yields and earnings breadth over the next 1–3 months. Avoid adding tactically if growth leadership remains narrow and accelerating; reconsider the diversification case if SCHD’s defensive sectors begin participating.
• Before increasing exposure, verify current holdings concentration, valuation, and dividend growth versus payout coverage. Persistent distribution deceleration or material deterioration in underlying cash-flow coverage would falsify the quality-and-compounding thesis.